mifepristone

A proposed California bill, AB 2540, would require community colleges with health centers to provide access to abortion pills starting in 2029 if funded, extending a 2019 law for public universities. Supporters argue it addresses access barriers for students, while campus health directors express concerns about funding and capacity.

A California bill would require community colleges with health centers to provide medication abortion starting in 2029 if the Legislature provides funding. The bill, AB 2540, follows a 2019 law for universities and aims to address access barriers, but health center directors note staffing and infrastructure challenges.

New laws in Iowa, Mississippi, and Tennessee restrict access to abortion medications and limit minors' access to sexual and reproductive healthcare, including the HPV vaccine. A federal lawsuit challenges FDA rules allowing mifepristone to be dispensed via telehealth, with nationwide implications.

Planned Parenthood expanded medication abortion access in Missouri starting June 22, following a court ruling that struck down state laws restricting abortion care. The Gladstone clinic in Kansas City's Northland became the fourth Missouri location offering medication abortion, with appointments filling quickly due to the new availability.

New laws in Iowa, Mississippi, and Tennessee restrict access to abortion medications and HPV vaccines for minors, effective July 1. The laws require in-person dispensing of abortion pills and prohibit minors under 18 from consenting to STD-related vaccinations in Iowa. A federal lawsuit challenges FDA rules allowing telehealth dispensing of mifepristone, which could impact nationwide access.

New laws in Iowa, Mississippi, and Tennessee restrict access to abortion medications like mifepristone and misoprostol and limit minors' access to the HPV vaccine. A federal lawsuit challenges FDA rules allowing telehealth dispensing of mifepristone, with nationwide implications.

California is challenging claims by Heartbeat International and RealOptions Inc. that a progesterone-based treatment can reverse the effects of the abortion drug mifepristone. A trial in Alameda County Superior Court heard testimony from Dr. Mitchell Creinin, who stated there is no scientific evidence supporting the safety or efficacy of the abortion pill reversal protocol. The state seeks to stop the organizations from making false claims and impose fines.

A pro-life group reported that nearly 330,000 abortion pills were shipped to states with abortion restrictions between July 2023 and December 2025 via blue state shield laws, which protect out-of-state providers from prosecution. The report cites data showing monthly shipments nearly tripled during this period, with 15,000 pills sent monthly to conservative states.

A pro-life group reported that nearly 330,000 abortion pills were shipped to states with abortion restrictions between July 2023 and December 2025 under blue state shield laws, which the group claims enabled abortion numbers in conservative states to remain at or above pre-Dobbs levels. The report cites data showing monthly shipments nearly tripled during this period, from 5,400 pills in July 2023 to 14,870 in December 2025.

Telehealth providers report that banning mifepristone, a key abortion pill, has not halted access as patients continue to receive misoprostol, the other drug used in medication abortions. Legal battles over mailing abortion pills persist, but experts argue widespread knowledge and distribution make restrictions ineffective.

Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to classify mifepristone, an abortion medication, as a water contaminant. Environmental experts and the Center for Biological Diversity state there is no evidence of harm from mifepristone in water systems, citing a 1996 FDA statement and common drug trace amounts in water.

Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to classify mifepristone, an abortion medication, as a water contaminant. Environmental experts state there is no evidence that mifepristone in wastewater harms humans or the environment, while the request cites a 1996 FDA statement acknowledging the drug may enter the environment but noting harmful effects are 'not anticipated.'

Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to classify the abortion medication mifepristone as a water contaminant. Environmental experts and advocacy groups state there is no evidence that mifepristone harms water systems or humans, while states have introduced legislation to test for the drug in water.

Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to classify the abortion medication mifepristone as a water contaminant, citing a 1996 FDA statement. Environmental experts and the Center for Biological Diversity state there is no evidence mifepristone harms water systems or humans, while state lawmakers in seven states introduced bills addressing medication abortion's environmental impact.

Louisiana is attempting to block nationwide mail distribution of mifepristone, an abortion medication, by citing the Comstock Act. The FDA had allowed mail delivery of the drug since 2023, but Louisiana argues this violates federal law. The Supreme Court recently sent the case back for review after overturning a lower court's halt to distribution.

Fourteen state attorneys general and 19 GOP members of Congress are urging the EPA to regulate mifepristone, an abortion medication, as a water contaminant. Environmental experts state there is no evidence that mifepristone harms water systems, while the request references a 1996 FDA statement acknowledging potential environmental entry but no anticipated harm.

Fourteen Republican state attorneys general and 19 GOP members of Congress are urging the EPA to regulate mifepristone as a water contaminant, citing environmental concerns. Experts and the Center for Biological Diversity state there is no evidence mifepristone harms water systems or humans, while the FDA noted in 1996 that environmental effects were 'not anticipated.'

Fourteen state attorneys general and 19 GOP members of Congress are urging the EPA to classify mifepristone, an abortion medication, as a water contaminant. Environmental experts state there is no evidence mifepristone in wastewater harms humans or the environment.

The Alabama Attorney General's Office threatened legal action against six companies distributing abortion-inducing medication, citing Alabama's near-total abortion ban. The office referenced a controversial study from a conservative think tank and acknowledged the action might inadvertently publicize access points for abortion pills.

Wisconsin Democratic lawmakers and reproductive rights advocates called for state-level protections for birth control, citing potential federal threats from the Trump administration and the Supreme Court. They referenced the 1965 Griswold v. Connecticut decision and concerns that the Dobbs ruling could lead to challenges against contraception access.

Telehealth access to abortion pills is critical for domestic violence survivors, as highlighted by two women who used medication abortions to escape abusive relationships. A Louisiana lawsuit challenges the FDA's 2023 rule allowing telehealth prescriptions for mifepristone, with courts temporarily blocking and then reinstating the rule amid ongoing legal battles.

Telehealth access to abortion pills is critical for domestic violence survivors, as highlighted by personal accounts of women who used medication abortions to escape abusive relationships. A Louisiana lawsuit challenges the FDA's 2023 rule allowing telehealth prescriptions of mifepristone, with courts temporarily blocking it before the Supreme Court paused the decision.

Telehealth access to the abortion pill mifepristone is critical for domestic violence survivors, as highlighted by personal accounts of Kaelah Oberdorf and Carrie Frail, who relied on medication abortions during abusive relationships. A Louisiana lawsuit challenges the FDA's 2023 rule allowing telehealth prescriptions, with courts temporarily blocking the rule before the Supreme Court paused the decision.

Telehealth access to abortion pills is critical for domestic violence survivors, as highlighted by two women who relied on medication abortions to escape abusive relationships. A Louisiana lawsuit challenges the FDA's 2023 rule allowing telehealth prescriptions of mifepristone, a drug used for early pregnancy termination, while advocates stress its importance for discreet care.

The FDA has launched a study on the abortion pill mifepristone. Health experts warn that the ongoing review could bypass established scientific evidence.

The FDA is conducting a safety review of the abortion drug mifepristone. This action could lead to restrictions on its use and distribution, supported by anti-abortion groups as a potential victory for their cause.

Telehealth access to abortion pills is critical for domestic violence survivors, as seen in cases like Kaelah Oberdorf and Carrie Frail, who relied on medication abortions to escape abusive relationships. A Louisiana lawsuit challenges the FDA's 2023 rule allowing telehealth prescriptions for mifepristone, with courts temporarily blocking and then reinstating the rule amid ongoing legal battles.

The FDA is reviewing a drug approval program initiated by former commissioner Marty Makary after receiving mixed feedback, and has launched a safety study of the mifepristone abortion pill, potentially leading to distribution restrictions under the Trump administration. Antiabortion groups and Republican lawmakers supported the study, which is expected to take six months.

Telehealth access to the abortion pill mifepristone is critical for domestic violence survivors, according to advocates and survivors like Kaelah Oberdorf and Carrie Frail, who credited medication abortion with enabling them to leave abusive relationships safely. A Louisiana lawsuit challenges the FDA’s 2023 rule allowing telehealth prescriptions for mifepristone, with courts temporarily blocking the rule before the Supreme Court paused the decision.

The FDA has initiated a safety study of the abortion pill mifepristone, as confirmed by a senior FDA official to CBS News. This move could lead to the Trump administration imposing restrictions on the medication's access.

A Columbus-based religious advocacy group, the Center for Christian Virtue, has urged federal prosecutors in Ohio to enforce the 1873 Comstock Act against mail-order providers of abortion medications like mifepristone. The group argues that prior non-enforcement of the law was a policy choice, not a legal determination of unenforceability, as the Supreme Court has not yet banned mail-order abortion drug distribution.

The U.S. Supreme Court temporarily allowed telehealth access to abortion medication nationwide while Louisiana's lawsuit against the FDA continues. The FDA had permitted remote prescriptions for mifepristone in 2023, but the 5th Circuit Court initially blocked it, citing state abortion bans. Other states like Florida, Oklahoma, Texas, and Iowa have laws restricting mail delivery of abortion pills.

Planned Parenthood is now offering abortion pills mifepristone and misoprostol in Washington state and Hawaii for residents to obtain preemptively and store at home in case they need to terminate a pregnancy in the future. This represents an expansion of medication abortion access in these two states.

Planned Parenthood is now offering abortion pills mifepristone and misoprostol in Washington state and Hawaii for residents to obtain and store preemptively in case they need to end a pregnancy in the future. This initiative allows individuals to have the medication available without needing to obtain a prescription at the time of use.

A study in the Journal of the American Medical Association found that patients experiencing miscarriage in states with abortion bans have fewer treatment options, including a shift away from the two-drug regimen of mifepristone and misoprostol toward less effective misoprostol-only treatments and increased expectant management. The study highlights risks like higher chances of hemorrhage and infection due to these changes.

A study found that pregnant patients experiencing miscarriage in states with abortion bans have fewer healthcare options, including a shift away from the recommended two-drug regimen (mifepristone and misoprostol) to less effective misoprostol-only treatments. The study also noted increased use of expectant management, which carries higher risks of complications.

A study published in the Journal of the American Medical Association found that pregnant patients experiencing miscarriage in states with abortion bans have fewer treatment options, including a shift away from the recommended two-drug regimen (mifepristone and misoprostol) to less effective methods. The study also noted increased use of expectant management, which carries higher risks of complications.

A study in the Journal of the American Medical Association found that pregnant patients experiencing miscarriage in states with abortion bans have fewer treatment options, including a shift away from the recommended two-drug regimen (mifepristone and misoprostol) to less effective misoprostol-only treatments and increased use of expectant management. The study highlights risks like hemorrhage and infection due to reduced access to standard care.

The Supreme Court ruled to continue telehealth access to abortion drug mifepristone, despite dissent from Justices Clarence Thomas and Samuel Alito. The decision allows access to continue, but advocates warn that the threat to abortion access is still present. Abortions have increased since the Dobbs v. Jackson decision in 2022.

The Supreme Court temporarily preserved telehealth access to mifepristone, a medication used in abortions, amid a legal challenge from Louisiana. The case involves the Comstock Act, an 1873 law that could block mailing abortion-related drugs, potentially impacting states like Virginia where abortion is currently legal. Activist Mark Lee Dickson advocates enforcing the law to create a national abortion ban, while telehealth provider Hey Jane emphasizes its role in reproductive healthcare access.